Computer scientist, physicist, entrepreneur and investor whose work spans artificial intelligence and complex systems. He is the founder and managing partner of Reified.
Eli Lilly's GLP-1 franchise (Mounjaro, retatrutide) is driving it toward a trillion-dollar valuation, and the market is clearly signaling that longevity drugs and AI are the two obvious industries of the future.
Compute is becoming a financial commodity, but the massive capital expenditure required for AI infrastructure cannot scale efficiently without futures, options and other hedging instruments. Orin is building that missing market infrastructure.
SpaceX can hit $1T revenue by 2030 either through Optimus robots taking over physical labor economy (Path 1) or by building Terra Fab to vertically integrate semiconductor manufacturing and replace TSMC in partnership with Nvidia (Path 2).